90 filings
Page 3 of 5
8-K
vkzz1fc1
10 Nov 22
Nuvalent Reviews Corporate and Pipeline Achievements and Reports Third Quarter 2022 Financial Results
6:37am
8-K
z4s929h626l87rqklwkw
1 Nov 22
Nuvalent Announces Pricing of Public Offering of Common Stock
5:19pm
424B5
fo7lv08zzp23
1 Nov 22
Prospectus supplement for primary offering
5:17pm
424B5
a9ydec5k4n
1 Nov 22
Prospectus supplement for primary offering
5:16pm
424B5
xgugi6f 1kwh
31 Oct 22
Prospectus supplement for primary offering
7:21am
8-K
t2i7 b6c747
28 Oct 22
Other Events
6:05am
8-K
f5hkhowoa 7o
6 Oct 22
Departure of Directors or Certain Officers
4:16pm
424B5
ap054 u43bnf
17 Aug 22
Prospectus supplement for primary offering
4:23pm
EFFECT
2wzdr9u
17 Aug 22
Notice of effectiveness
12:15am
CORRESP
htv2t6
12 Aug 22
Correspondence with SEC
12:00am
UPLOAD
pynbtg 0p7
11 Aug 22
Letter from SEC
12:00am
S-3
nn9ggb5ofmyx47e9
10 Aug 22
Shelf registration
8:35am
8-K
j1xi8cjc37b
10 Aug 22
Nuvalent Highlights Execution Across Pipeline of Novel Kinase Inhibitors and Reports Second Quarter 2022 Financial Results
12:00am
8-K
mp4li4l0hsl3yj3t04pe
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
gnyni3f1f6371cscpnp
12 May 22
Nuvalent Highlights Pipeline and Business Progress and Reports First Quarter 2022 Financial Results
6:45am
DEFA14A
wi0ycgu3dyspu
29 Apr 22
Additional proxy soliciting materials
4:10pm
DEF 14A
55078fn
29 Apr 22
Definitive proxy
4:07pm
8-K
xg7u4w27
31 Mar 22
Departure of Directors or Certain Officers
6:48am